Company Day One Biopharmaceuticals, Inc.
Equities
DAWN
US23954D1090
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.44 USD | -1.38% | +31.53% | +19.01% |
04-29 | North American Morning Briefing : Investors Brace -2- | DJ |
04-24 | Needham Adjusts Price Target on Day One Biopharmaceuticals to $33 From $30, Keeps Buy Rating | MT |
Business Summary
Number of employees: 155
Managers
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 18-10-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Charles York
DFI | Director of Finance/CFO | 47 | 21-01-31 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 22-09-30 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 23-04-30 |
Jaa Roberson
HRO | Human Resources Officer | - | 21-09-12 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 23-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 21-08-16 |
Natalie Holles
BRD | Director/Board Member | 51 | 21-01-31 |
John Josey
BRD | Director/Board Member | 63 | 20-08-31 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director/Board Member | 37 | 19-11-30 | |
Director/Board Member | 48 | 21-02-28 | |
William Grossman
BRD | Director/Board Member | 54 | 01-16 |
Garry Nicholson
CHM | Chairman | 69 | 22-09-11 |
Habib Dable
BRD | Director/Board Member | 54 | 01-16 |
Dan Becker
BRD | Director/Board Member | 49 | 19-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 87,377,163 | 70,029,780 ( 80.15 %) | 0 | 80.15 % |
Company contact information
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.01% | 1.55B | |
+21.40% | 42.68B | |
-2.56% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.08% | 24.94B | |
-19.92% | 18.96B | |
+30.08% | 12.3B | |
-2.59% | 11.95B | |
-2.73% | 11.55B |
- Stock Market
- Equities
- DAWN Stock
- Company Day One Biopharmaceuticals, Inc.